$14.05
-0.73 (-4.94%)
Dendreon Corp (NASDAQ:DNDN)
CAPS Rating:
A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.
A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.